Fortress Biotech
Biotechnology, 2 Gansevoort St, Bay Harbor Islands, Florida, 10014, United States, 11-50 Employees
Phone Number: 17*********
Who is FORTRESS BIOTECH
Fortress Biotech, Inc. (Fortress) is an innovative biopharmaceutical company that was ranked in Deloittes 2019 and 2020 Technology Fast 500TM, annual rankings of the fastest-growing North...
Read More
- Headquarters: 2 Gansevoort St, Bay Harbor Islands, Florida, 10014, United States
- Employees: 11-50
- Revenue: $50 Million to $100 Million
- CEO: Lindsay Rosenwald
Industry: Biotechnology
SIC Code: 2834
Does something look wrong? Fix it. | View contact records from FORTRESS BIOTECH
Fortress Biotech Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Fortress Biotech
Answer: Fortress Biotech's headquarters are located at 2 Gansevoort St, Bay Harbor Islands, Florida, 10014, United States
Answer: Fortress Biotech's phone number is 17*********
Answer: Fortress Biotech's official website is https://fortressbiotech.com
Answer: Fortress Biotech's revenue is $50 Million to $100 Million
Answer: Fortress Biotech's SIC: 2834
Answer: Fortress Biotech has 11-50 employees
Answer: Fortress Biotech is in Biotechnology
Answer: Fortress Biotech contact info: Phone number: 17********* Website: https://fortressbiotech.com
Answer: Fortress Biotech, Inc. (Fortress) is an innovative biopharmaceutical company that was ranked in Deloittes 2019 and 2020 Technology Fast 500TM, annual rankings of the fastest-growing North American companies in the technology, media, telecommunications, life sciences and energy tech sectors, based on percentages of fiscal year revenue growth over three-year periods. Fortress is focused on acquiring, developing and commercializing high-potential marketed and development-stage pharmaceutical products and product candidates. The company has seven marketed prescription pharmaceutical products and over 25 programs in development at Fortress, at its majority-owned and majority-controlled partners and at partners it founded and in which it holds significant minority ownership positions. Such product candidates span six large-market areas, including oncology, rare diseases and gene therapy, which allow it to create value for shareholders. Fortress advances its diversified pipeline through a streamlined operating structure that fosters efficient drug development. The Fortress model is driven by a world-class business development team that is focused on leveraging its significant biopharmaceutical industry expertise to further expand the companys portfolio of product opportunities. Fortress has established partnerships with some of the worlds leading academic research institutions and biopharmaceutical companies to maximize each opportunity to its full potential, including Alexion Pharmaceuticals, Inc., AstraZeneca, City of Hope, Fred Hutchinson Cancer Research Center, St. Jude Childrens Research Hospital and Nationwide Childrens Hospital.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month